Importance of Preclinical Research in the Development of Neuroprotective Strategies for Ischemic Stroke
- 1 May 2014
- journal article
- review article
- Published by American Medical Association (AMA) in JAMA Neurology
- Vol. 71 (5) , 634-639
Abstract
Review from JAMA Neurology — Importance of Preclinical Research in the Development of Neuroprotective Strategies for Ischemic StrokeKeywords
This publication has 32 references indexed in Scilit:
- The exact science of stroke thrombolysis and the quiet art of patient selectionBrain, 2013
- 1,026 Experimental treatments in acute strokeAnnals of Neurology, 2006
- Glycine antagonist (gavestinel) in neuroprotection (GAIN International) in patients with acute stroke: a randomised controlled trialThe Lancet, 2000
- Pathobiology of ischaemic stroke: an integrated viewTrends in Neurosciences, 1999
- Reversible middle cerebral artery occlusion without craniectomy in rats.Stroke, 1989
- Thresholds in cerebral ischemia - the ischemic penumbra.Stroke, 1981
- Focal Cerebral Ischaemia in the Rat: 1. Description of Technique and Early Neuropathological Consequences following Middle Cerebral Artery OcclusionJournal of Cerebral Blood Flow & Metabolism, 1981
- A new model of bilateral hemispheric ischemia in the unanesthetized rat.Stroke, 1979
- Free radicals in cerebral ischemia.Stroke, 1978
- THROMBOLYSIS WITH FIBRINOLYSIN IN CEREBRAL ARTERIAL OCCLUSIONJAMA, 1958